加压素-话题@MedSci

#加压素#

31篇内容 | 1673人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183119, encodeId=499b21831199a, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a> <a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Pediatr Res：加压素治疗新生儿难治性急性肺动脉高压, objectType=article, longId=810428, objectId=bddd810428de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867287231_4754896.png, objectUrl=/article/show_article.do?id=bddd810428de, replyNumber=0, likeNumber=63, createdTime=2024-01-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bddd810428de, moduleTitle=Pediatr Res：加压素治疗新生儿难治性急性肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bddd810428de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1992066, encodeId=66651992066bb, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=权威发布｜特利加压素在肝硬化并发症临床应用的实践指导(2021版), objectType=article, longId=738999, objectId=0694e3899931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0694e3899931, replyNumber=0, likeNumber=60, createdTime=2023-08-04, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0694e3899931, moduleTitle=权威发布｜特利加压素在肝硬化并发症临床应用的实践指导(2021版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0694e3899931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992065, encodeId=68471992065bf, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=加压素和呼吸：抗利尿激素对呼吸系统的影响, objectType=article, longId=221662, objectId=54ce22166236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54ce22166236, replyNumber=0, likeNumber=80, createdTime=2022-09-15, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54ce22166236, moduleTitle=加压素和呼吸：抗利尿激素对呼吸系统的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54ce22166236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992064, encodeId=325f1992064b8, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=JAMA：血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复, objectType=article, longId=218146, objectId=2b23218146ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b23218146ee, replyNumber=0, likeNumber=83, createdTime=2022-03-25, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b23218146ee, moduleTitle=JAMA：血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b23218146ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992062, encodeId=bd0919920624d, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, objectType=article, longId=208183, objectId=5b2d208183e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b2d208183e4, replyNumber=0, likeNumber=91, createdTime=2021-11-02, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b2d208183e4, moduleTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b2d208183e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992063, encodeId=1c2e199206303, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, objectType=article, longId=211429, objectId=be23211429df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be23211429df, replyNumber=0, likeNumber=92, createdTime=2022-01-23, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be23211429df, moduleTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be23211429df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992061, encodeId=f2061992061bd, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率, objectType=article, longId=204222, objectId=abb0204222a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abb0204222a7, replyNumber=0, likeNumber=80, createdTime=2021-08-06, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abb0204222a7, moduleTitle=Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abb0204222a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992058, encodeId=af5d1992058ce, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=JAMA:减少加压素暴露不能降低老年血管扩张性低血压危重患者的90天死亡率, objectType=article, longId=189848, objectId=f16e1898480c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f16e1898480c, replyNumber=0, likeNumber=70, createdTime=2020-12-02, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f16e1898480c, moduleTitle=JAMA:减少加压素暴露不能降低老年血管扩张性低血压危重患者的90天死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f16e1898480c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992060, encodeId=ad2c1992060d2, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=特利加压素治疗1型肝肾综合症：获得FDA咨询委员会的投票支持, objectType=article, longId=197639, objectId=2d3819e639a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d3819e639a3, replyNumber=0, likeNumber=66, createdTime=2021-06-11, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d3819e639a3, moduleTitle=特利加压素治疗1型肝肾综合症：获得FDA咨询委员会的投票支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d3819e639a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992059, encodeId=8fa31992059d4, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=JAMA：血管加压素联合儿茶酚胺与单独应用儿茶酚胺治疗分配性休克患者房颤发生率的比较：系统回顾及META-分析, objectType=article, longId=190678, objectId=abfb1906e8e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abfb1906e8e1, replyNumber=0, likeNumber=67, createdTime=2020-09-01, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abfb1906e8e1, moduleTitle=JAMA：血管加压素联合儿茶酚胺与单独应用儿茶酚胺治疗分配性休克患者房颤发生率的比较：系统回顾及META-分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abfb1906e8e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992057, encodeId=4119199205e94, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=2019 CCCS临床实践指南：血管加压素和加压素类似物在分布性休克危重患者中的应用, objectType=article, longId=184709, objectId=4ab8184e0906, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ab8184e0906, replyNumber=0, likeNumber=55, createdTime=2020-01-18, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ab8184e0906, moduleTitle=2019 CCCS临床实践指南：血管加压素和加压素类似物在分布性休克危重患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ab8184e0906)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992055, encodeId=56371992055ab, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=JAMA Surg：失血性休克创伤患者接受精氨酸加压素可降低血液制品消耗, objectType=article, longId=178658, objectId=a9421e865851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9421e865851, replyNumber=0, likeNumber=78, createdTime=2020-01-11, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9421e865851, moduleTitle=JAMA Surg：失血性休克创伤患者接受精氨酸加压素可降低血液制品消耗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9421e865851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992056, encodeId=c587199205663, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Oncogene：靶向加压素2型受体治疗肾细胞癌研究, objectType=article, longId=181947, objectId=645118194e91, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=645118194e91, replyNumber=0, likeNumber=87, createdTime=2019-11-03, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=645118194e91, moduleTitle=Oncogene：靶向加压素2型受体治疗肾细胞癌研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=645118194e91)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992054, encodeId=9cb7199205494, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Mallinckrodt的特利加压素达到1型肝肾综合症III期研究的主要目标, objectType=article, longId=177803, objectId=fbaf1e78035c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbaf1e78035c, replyNumber=0, likeNumber=76, createdTime=2019-11-05, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbaf1e78035c, moduleTitle=Mallinckrodt的特利加压素达到1型肝肾综合症III期研究的主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbaf1e78035c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992053, encodeId=241e19920533d, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=IJLH：定量分析成年1型冯•威利斯布兰德病患者的去氨加压素(DDAVP)反应, objectType=article, longId=175932, objectId=17061e593243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17061e593243, replyNumber=0, likeNumber=75, createdTime=2020-03-12, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17061e593243, moduleTitle=IJLH：定量分析成年1型冯•威利斯布兰德病患者的去氨加压素(DDAVP)反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17061e593243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992052, encodeId=15d41992052c0, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?, objectType=article, longId=174655, objectId=52951e465521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52951e465521, replyNumber=0, likeNumber=82, createdTime=2020-05-25, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52951e465521, moduleTitle=脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52951e465521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992051, encodeId=faa71992051f6, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=【临床重症】特利加压素？去甲肾上腺素？亦或都用在脓毒性休克中？, objectType=article, longId=161670, objectId=792d1616e0fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=792d1616e0fd, replyNumber=0, likeNumber=63, createdTime=2019-10-29, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=792d1616e0fd, moduleTitle=【临床重症】特利加压素？去甲肾上腺素？亦或都用在脓毒性休克中？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=792d1616e0fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992049, encodeId=e4651992049a3, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Intens Care Med：脓毒性休克患者输注特利加压素与去甲肾上腺素的疗效比较！, objectType=article, longId=142973, objectId=195e1429e38e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195e1429e38e, replyNumber=0, likeNumber=68, createdTime=2018-08-20, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195e1429e38e, moduleTitle=Intens Care Med：脓毒性休克患者输注特利加压素与去甲肾上腺素的疗效比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=195e1429e38e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992050, encodeId=456b199205043, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Sci Rep：小儿单独遗尿症状的警报治疗与去氨加压素治疗系统回顾与元分析, objectType=article, longId=154435, objectId=922a1544359f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922a1544359f, replyNumber=0, likeNumber=78, createdTime=2019-08-25, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922a1544359f, moduleTitle=Sci Rep：小儿单独遗尿症状的警报治疗与去氨加压素治疗系统回顾与元分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922a1544359f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992047, encodeId=a05e199204e1f, content=<a href='/topic/show?id=11b13296e8e' target=_blank style='color:#2F92EE;'>#加压素#</a>, objectTitle=Intensive Care Med：血管加压素治疗休克——高vs低血压目标对结局有何影响？, objectType=article, longId=130487, objectId=873213048ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873213048ecb, replyNumber=0, likeNumber=86, createdTime=2018-08-05, rootId=0, userName=fyxzlh, userId=c9df476, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873213048ecb, moduleTitle=Intensive Care Med：血管加压素治疗休克——高vs低血压目标对结局有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=873213048ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

加压素

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肺动脉高压# #加压素#

Pediatr Res：加压素治疗新生儿难治性急性肺动脉高压

2024-01-22发表于上海

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

权威发布｜特利加压素在肝硬化并发症临床应用的实践指导(2021版)

2023-08-04

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

加压素和呼吸：抗利尿激素对呼吸系统的影响

2022-09-15

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

JAMA：血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复

2022-03-25

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

NEJM：特利加压素联合白蛋白治疗1型肝肾综合征

2021-11-02

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关

2022-01-23

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率

2021-08-06

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

JAMA:减少加压素暴露不能降低老年血管扩张性低血压危重患者的90天死亡率

2020-12-02

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

特利加压素治疗1型肝肾综合症：获得FDA咨询委员会的投票支持

2021-06-11

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

JAMA：血管加压素联合儿茶酚胺与单独应用儿茶酚胺治疗分配性休克患者房颤发生率的比较：系统回顾及META-分析

2020-09-01

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

2019 CCCS临床实践指南：血管加压素和加压素类似物在分布性休克危重患者中的应用

2020-01-18

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

JAMA Surg：失血性休克创伤患者接受精氨酸加压素可降低血液制品消耗

2020-01-11

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Oncogene：靶向加压素2型受体治疗肾细胞癌研究

2019-11-03

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Mallinckrodt的特利加压素达到1型肝肾综合症III期研究的主要目标

2019-11-05

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

IJLH：定量分析成年1型冯•威利斯布兰德病患者的去氨加压素(DDAVP)反应

2020-03-12

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?

2020-05-25

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

【临床重症】特利加压素？去甲肾上腺素？亦或都用在脓毒性休克中？

2019-10-29

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Intens Care Med：脓毒性休克患者输注特利加压素与去甲肾上腺素的疗效比较！

2018-08-20

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Sci Rep：小儿单独遗尿症状的警报治疗与去氨加压素治疗系统回顾与元分析

2019-08-25

fyxzlh (审核中...)

前往app查看评论内容

#加压素#

Intensive Care Med：血管加压素治疗休克——高vs低血压目标对结局有何影响？

2018-08-05

科室
- - 订阅+
  - 更多科室
工具
服务